- Health officials say a suspected hantavirus is on a ship.
- Three passengers have died from a serious breathing illness.
- Other passengers and crew are also feeling sick now.
- Doctors and health teams are checking everyone on board.
- Officials have not said the ship name yet.
- They are testing people and tracing contacts on board.
- Some animals can pass the virus to people in places.
- Experts want to know if people can spread it.
Difficult words
- hantavirus — a virus that can cause a serious illness
- passenger — person who travels on a vehiclepassengers
- official — person who works for the government or authorityofficials
- test — check people for a disease or problemtesting
- trace — find people who had contact with someonetracing
- crew — people who work on a ship or plane
- spread — move or pass a disease to other people
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever been on a ship?
- What would you do if you felt sick on a ship?
- Do you think animals can make people sick?
Related articles
Pet care at One Health Clinic helps youth get medical care
A study found that youth experiencing homelessness were more likely to receive medical care when clinics also offered veterinary care for their pets. The research looked at clients of the One Health Clinic in downtown Seattle and records from 2019–2022.
Inequality and Pandemics: Why Science Alone Is Not Enough
Matthew M. Kavanagh says science can detect viruses and make vaccines fast, but rising inequality makes pandemics worse. He proposes debt relief, shared technology, regional manufacturing and stronger social support to stop future crises.
AI and Wearable Devices for Type 2 Diabetes
A meta-review from the University at Buffalo examines AI-enhanced wearable devices for Type 2 diabetes and prediabetes. The study finds predictive benefits and important limits, and calls for larger, more transparent studies before routine clinical use.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.